References
- Sills G J, Butler E, Thompson G G, Brodie M J. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study. Seizure 1999; 8:404–411. [PUBMED], [INFOTRIEVE], [CSA]
- Leppik I E, Gram L, Deaton R, Sommerville K W. Safety of tiagabine: summary of 53 trials. Epilepsy Res 1999; 33:235–246. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leach J P, Stolarek I, Brodie M J. Deliberate overdose with the novel anticovulsant tiagabine. Seizure 1995; 4:155–157. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Viner K, Clifton H JC, Hryhorczuk D O, Paloueck F P, Williams R H, Fischbein C B. Status epilepticus following acute tiagabine overdose. (Abstract). J Toxicol Clin Toxicol 1999; 37:638. [CSA]
- Ostrovsky D, Spanaki M V, Morris G L. Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 2002; 43:773–774. [CSA], [CROSSREF]
- Kellinghaus C, Dziewas R, Ludermann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 2002; 11:243–249., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Trinka E, Moroder T, Nagler M, Staffen W, Loscher W, Ladurner G. Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure 1999; 8:41–44. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhu Y, Vaughn B V. Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure. Seizure 2002; 11:57–59. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mangano S, Cusumano L, Fontana A. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Brain Dev 2003; 27:518–521. [CSA], [CROSSREF]
- Skodda S, Kramer I, Spittler J F, Gehlen W. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment. J Neurol 2001; 248:109–112. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Balslev T, Uldall P, Buchholt J. Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients. Eur J Pediatr Neurol 2000; 4:169–170. [CSA], [CROSSREF]
- Brouns R, Van Paesschen W. Recurrent complex partial status epilepticus associated with tiagabine rechallenge. Acta Neurol Belg 2002; 102:19–20. [PUBMED], [INFOTRIEVE], [CSA]
- Piccinelli P, Borgatti R, Perucca E, Tofani A, Donati G, Balottin U. Frontal non-convulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria. Epilepsia 2000; 41:1485–1488. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cantrell F L, Ritter M, Himes E. Intentional overdose with tiagabine: an unusual clinical presentation. J Emerg Med 2004; 27:271–272. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gustavson L E, Mengel H B. Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses. Epilepsia 1995; 36(6):605–611. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lau A H, Gustavson L E, Sperelakis R, Lam N P, El-Shourbagy T, Qian J X, Layden T. Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function. Epilepsia 1997; 38(4):445–451. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]